Newsletter DRUG SAFETY INSTITUTE INVITED BY ABIMIP TO ANVISA! On March, 21st, 2019, Brand Institute (BI) and subsidiary Drug Safety Institute (DSI), ...BrandinstituteJune 21, 2019
Newsletter GOVERNMENT NAMING OFFICIALS JOIN BI/DSI Mr. Bridges joined DSI – Rockville in May 2018 as Global President. Prior to joining …BrandinstituteMay 12, 2018
Newsletter CONGRATULATIONS TO BIOMARIN FOR WINNING FIERCEBIOTECH’S 2018 For the second time in a row, a BioMarin drug brand name has won FierceBiotech’s …BrandinstituteApril 20, 2018
Newsletter DSI UPDATES GLOBAL NAME SAFETY RESEARCH MODEL Drug Safety Institute (DSI) has revised our name safety research methodology based on newly discovered review …BrandinstituteFebruary 20, 2018
Newsletter DSI offers new service for HUMAN FACTORS STUDIES In accordance with FDA’s February 2016 Draft Guidance titled “Human Factors Studies and Related Clinical Study Considerations in …BrandinstituteJanuary 20, 2018